Matches in Nanopublications for { ?s ?p "[Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- assertion description "[Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP598737.RArSf1uE1emkNTR2PM2xkda99ZotrliI5UdHSUUAfEOW8130_assertion description "[Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP598737.RArSf1uE1emkNTR2PM2xkda99ZotrliI5UdHSUUAfEOW8130_provenance.
- NP1211596.RAcXlfisoM4UvObCeDhH1Ev0JB_aTN-mJDJB13EnJd3-c130_assertion description "[Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1211596.RAcXlfisoM4UvObCeDhH1Ev0JB_aTN-mJDJB13EnJd3-c130_provenance.
- NP1211595.RAmNvE9sf2XlARMU8wvyj0poPhxv7Y-eISjzV00-0hexs130_assertion description "[Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1211595.RAmNvE9sf2XlARMU8wvyj0poPhxv7Y-eISjzV00-0hexs130_provenance.
- NP465029.RAOcmTbclNMHkZJW7cMW_Mvaieyft3lbElUM50P3WrWrU130_assertion description "[Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP465029.RAOcmTbclNMHkZJW7cMW_Mvaieyft3lbElUM50P3WrWrU130_provenance.
- NP527501.RAHwWbGPW6fAw230vmrh3gioRjdHr0woTZy0czVYNz4R8130_assertion description "[Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP527501.RAHwWbGPW6fAw230vmrh3gioRjdHr0woTZy0czVYNz4R8130_provenance.
- NP1211594.RA60LI9m8YIYorvVKhMqWASx4pz74rLkB89rpWDLWn8uw130_assertion description "[Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1211594.RA60LI9m8YIYorvVKhMqWASx4pz74rLkB89rpWDLWn8uw130_provenance.